The Genetics, Epidemiology, and Early Detection of Brain Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 243
Special Issue Editors
Interests: high-grade glioma; low-grade glioma; brain metastasis; meningioma; skull base surgery; pediatric brain tumors; genetics and epigenetics of brain tumors
Special Issue Information
Dear Colleagues,
Brain tumors include a wide range of different neoplasms with significantly diverging treatment protocols and prognosis. Some of them are part of more complex syndromes, which require proper diagnostic examinations and follow-up regimens. In recent years, new diagnostic tools and targeted therapies have emerged, along with the awareness of specific molecular characteristics with significant therapeutic and prognostic value. However, there are still many knowledge gaps about the genetics and epigenetics of brain tumors. Better knowledge and understanding of the genetics and epidemiology of these tumors might improve their early detection and prognosis.
Therefore, we are pleased to invite you to submit your papers to this Special Issue, which will highlight the genetics, epigenetics and epidemiology of brain tumors as well as new diagnostic tools for the early detection of brain tumors. Both clinical and basic/preclinical aspects will be covered.
In this Special Issue, original research articles and reviews are welcome, along with expert opinions, systematic reviews and meta-analyses. Research areas may include (but are not limited to) the following: gliomas, meningiomas, ependymomas, metastases, hemangioblastomas, diagnostic tools, new therapeutical strategies and prognostic factors.
We look forward to receiving your contributions.
Prof. Dr. Stefan Linsler
Dr. Christoph Sippl
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genetics
- epigenetics
- glioma
- meningioma
- brain tumors
